Condition: Pancreatic Cancer · Sponsor: Tianjin Medical University Cancer Institute and Hospital
This study aims to further observe and evaluate whether the three-week administration of albumin-bound paclitaxel combined with gemcitabine is equivalent to the four-week administration in the treatment of inoperable locally advanced or metastatic pancreatic cancer
This description comes directly from the study's public registry record.
Liu rui, professor · 13602139003 · Liurui9003@163.com
Ji zhi, professor · 18526643284 · jizhikey@qq.com
Always discuss trial participation with your own doctor first.
| Rui Liu | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05035147